Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,034 | -6,161 | -8,558 | -9,605 | -8,218 |
| Depreciation Amortization | 1,049 | 1,334 | 1,098 | 723 | 660 |
| Accounts receivable | -150 | 270 | 76 | -497 | -547 |
| Other Working Capital | 26 | 287 | -1,087 | -148 | -290 |
| Other Operating Activity | 423 | 321 | 745 | 2,325 | 1,392 |
| Operating Cash Flow | $-2,686 | $-3,949 | $-7,725 | $-7,202 | $-7,003 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,680 | 2,320 | 6,094 | -9,943 | N/A |
| PPE Investments | -22 | -58 | -3,091 | -2,446 | -475 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 33 |
| Other Investing Activity | -13 | -41 | -469 | -30 | -395 |
| Investing Cash Flow | $1,645 | $2,222 | $2,533 | $-12,419 | $-837 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,197 |
| Debt Repayment | N/A | -26 | -195 | -589 | -125 |
| Common Stock Issued | 30 | N/A | 1,023 | 27,409 | 7,910 |
| Common Stock Repurchased | N/A | -5 | -4 | N/A | -1 |
| Dividend Paid | -37 | N/A | N/A | -39 | N/A |
| Other Financing Activity | -264 | -72 | -168 | -14 | -586 |
| Financing Cash Flow | $-270 | $-102 | $656 | $26,769 | $8,395 |
| Beginning Cash Position | 2,991 | 4,820 | 9,356 | 2,208 | 1,653 |
| End Cash Position | 1,679 | 2,991 | 4,820 | 9,356 | 2,208 |
| Net Cash Flow | $-1,312 | $-1,829 | $-4,536 | $7,148 | $554 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,686 | -3,949 | -7,725 | -7,202 | -7,003 |
| Capital Expenditure | -22 | -58 | -3,091 | -2,446 | -475 |
| Free Cash Flow | -2,708 | -4,007 | -10,816 | -9,648 | -7,478 |